Improving depression care for veterans with HIV
Implementation of Collaborative Care for Depression in VA HIV Clinics: Translating Initiatives for Depression Into Effective Solutions (HITIDES)
This study tests two different ways to improve depression care for veterans living with HIV to see which method helps them get better support.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 8 (estimated) |
| Sex | All |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 1 site (Little Rock, Arkansas) |
| Trial ID | NCT05901272 on ClinicalTrials.gov |
What this trial studies
This study evaluates the implementation of the HITIDES program, a collaborative care intervention designed to manage depression in Veterans Living with HIV (VLWH). It compares two strategies for engaging HIV clinics: one involving a local clinical champion and the other incorporating external facilitation. The study aims to assess the effectiveness and cost of these approaches in connecting veterans to improved depression care. By understanding the best methods for implementation, the study seeks to enhance mental health services for this population and optimize resource use within the VA system.
Who should consider this trial
Good fit: Ideal candidates for this study are veterans living with HIV who are experiencing symptoms of depression.
Not a fit: Patients who are not veterans or those without a diagnosis of HIV or depression may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly improve depression management for veterans living with HIV, leading to better mental health outcomes.
How similar studies have performed: Previous studies have shown that collaborative care models can effectively improve depression outcomes, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: The research team will work with VISN 10 to identify sites that * have an adequately sized (i.e. greater than 20) population of Veterans Living with HIV, * have adequate PHQ-2 screen data to assess depression prevalence, * can identify a clinical champion for implementation activities, * are willing to participate, and * allow for diversity and balance of clinic characteristics across arms (e.g. rate of referral to specialty mental health for VLWH and presence of HIV-only specialty clinic versus broad infectious disease clinic). * For criterion 5, these factors that are important will be determined with VISN 10 clinical leadership and the research advisory council. Randomization at the VAMC level has limited ability to completely balance observed and unobserved health-system factors. However, efforts to balance key site characteristics are important; therefore, site-level characteristics thought to impact implementation efforts were identified by building consensus among HIV, Hepatitis, and Related Conditions Program (HHRC) leadership and the HIV care and implementation experts on the research team. Data on the following observable site-level characteristics will be collected from these sites during Year 1 of the study: baseline PHQ-2 screen rate, clinic size (unique patients, provider full-time equivalents \[FTE\], change in enrollment over the past 3 years), and current care manager FTE. Based on the five criteria described above and the power calculation below, eight eligible sites will be selected. Sites will be grouped into four couplets based on balance of the identified site-level characteristics. Exclusion Criteria: -None.
Where this trial is running
Little Rock, Arkansas
- Central Arkansas Veterans Healthcare System , Little Rock, AR — Little Rock, Arkansas, United States (Recruiting)
Study contacts
- Principal investigator: Jacob T Painter, PhD PharmD — Central Arkansas Veterans Healthcare System , Little Rock, AR
- Study coordinator: Jacob T Painter, PhD PharmD
- Email: Jacob.Painter@va.gov
- Phone: (501) 257-1740
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.